Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma total assets
Total assets on the balance sheet at the end of each period.
Mereo BioPharma's total assets was $29.58M at Sep 30, 2026. For fiscal 2025 it was $45.92M, down 39.9% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.92M | -39.9% |
| FY2024 | Dec 31, 2024 | $76.39M | +14.9% |
| FY2023 | Dec 31, 2023 | $66.50M | -14.1% |
| FY2022 | Dec 31, 2022 | $77.41M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $29.58M | -44.8% |
| Q2 FY2026 | Jun 30, 2026 | $34.71M | -44.6% |
| Q1 FY2026 | Mar 31, 2026 | $40.61M | -40.6% |
| Q4 FY2025 | Dec 31, 2025 | $45.92M | -39.9% |
| Q3 FY2025 | Sep 30, 2025 | $53.60M | -39.6% |
| Q2 FY2025 | Jun 30, 2025 | $62.63M | -34.8% |
| Q1 FY2025 | Mar 31, 2025 | $68.32M | +22.1% |
| Q4 FY2024 | Dec 31, 2024 | $76.39M | +14.9% |
| Q3 FY2024 | Sep 30, 2024 | $88.75M | +14.6% |
| Q2 FY2024 | Jun 30, 2024 | $96.13M | – |
| Q1 FY2024 | Mar 31, 2024 | $55.94M | – |
| Q4 FY2023 | Dec 31, 2023 | $66.50M | – |
| Q4 FY2022 | Dec 31, 2022 | $77.41M | – |
See a number that looks wrong?